Admission to Official List and commencement of unconditional dealings

Not for release, publication or distribution in, or into, the United States,directly or indirectly, Canada, Australia or Japan

Admission to Official List and commencement of unconditional dealings on the Main Market of the London Stock Exchange

12 April, 2006 - Renovo Group plc, the biopharmaceutical product company developing a portfolio of drugs to prevent and reduce scarring in the skin and other external and internal parts of the body, is pleased to announce that its ordinary shares have been admitted to the Official List of the Financial Services Authority and to trading on London Stock Exchange's main market for listed securities (ticker symbol RNVO). Unconditional dealings in Renovo's ordinary shares commenced at 8.00am today.

Goldman Sachs International acted as Sponsor, Sole Global Coordinator, Sole Bookrunner and Joint Lead Manager for the Global Offer and Nomura Code Securities Limited acted as Joint Lead Manager.

Contacts

Goldman Sachs - Howard Rowe / Phil Raper / John Dwyer +44 20 7774 1000

M: Communications - Sarah Hamilton +44 7836 295291 or
Charlotte McMullen +44 7921 881800

This announcement may not be distributed, directly or indirectly, in or into the United States, Canada, Australia or Japan. This announcement does not constitute or form part of an offer to sell or issue, or any solicitation of an offer to buy or subscribe for, any securities referred to herein. The Global Offer and the distribution of this announcement and other information in connection with the Global Offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws
of any such jurisdiction.

The securities referred to herein may not be offered or sold in the United States absent registration, exemption from registration or in a transaction not subject to registration under the US Securities Act of 1933, as amended (the 'Securities Act'). Any public offering of securities to be made in the United States would be by means of a prospectus that could be obtained from the issuer or the selling security holder and that would contain detailed information about the Company and management, as well as financial statements. However, no public offering of securities in the United States is currently contemplated, and the securities referred to herein have not been and will not be registered under the Securities Act. Copies of this announcement are not being, and should not be, distributed or sent into the United States.